Doxorubicin for metastatic breast cancer: time for a change?
Muggia
Franco
F
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008081:Liposomes; D009362:Neoplasm Metastasis
D000903:Antibiotics, Antineoplastic; D008081:Liposomes; D004317:Doxorubicin